Delta Pharma, Inc.

Form 483 issued October 2, 2013 · Ripley, Mississippi

Inspection
Sep 24 – Oct 2, 2013
Investigator
Zada L. Giles
Observations
9
Pages
6
FEI number
3004034796

In short: On October 2, 2013, FDA issued a Form 483 with 9 observations to Delta Pharma, Inc. in Ripley, Mississippi (FEI 3004034796) after an inspection that ran Sep 24 – Oct 2, 2013. The investigator was Zada L. Giles. Most observations concern facilities & equipment and production; the most-cited regulation is 21 CFR 211.42 (design and construction features).

At a glance

Facilities & equipment and production account for 7 of 9 observations.

Facilities & equipment5
Production2
Materials2

What FDA observed

Preview: the opening words of each observation
  1. 01

    Procedures designed to prevent microbiological contamination of drug products purporting to be sterile do not include…

  2. 02

    Aseptic processing areas are deficient regarding the system…

  3. 03

    Aseptic processing areas are deficient regarding air supply that is filtered through high-efficiency particulate air…

  4. 04

    Equipment used in the manufacture, processing, packing or holding of drug products is not of appropriate…

5 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Delta Pharma, Inc.?

FDA listed 9 observations on this Form 483, mostly about facilities & equipment, production and materials. The most-cited regulation is 21 CFR 211.42 (design and construction features). The opening words of each observation are shown on this page.

Who inspected Delta Pharma, Inc.?

Zada L. Giles is named on this Form 483, for the inspection of Sep 24 – Oct 2, 2013. Each investigator has a profile showing what they cite most.

When was Delta Pharma, Inc. inspected by FDA?

The inspection ran Sep 24 – Oct 2, 2013, and the Form 483 is dated October 2, 2013.

How do I get the full Form 483 for Delta Pharma, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free